Genetically Increasing Myoc Expression Supports a Necessary Pathologic Role of Abnormal Proteins in Glaucoma

REFERENCES

• Ahmed, F., Torrado M., Johnson E., Morrison J., and Tomarev S. I.. 2001. Changes in mRNA levels of the Myoc/Tigr gene in the rat eye after experimental elevation of intraocular pressure or optic nerve transection. Investig Ophthalmol. Vis. Sci. 42:3165–3172.
   PubMedGoogle Scholar
• Alward, W. L., Kwon Y. H., Khanna C. L., Johnson A. T., Hayreh S. S., Zimmerman M. B., Narkiewicz J., Andorf J. L., Moore P. A., Fingert J. H., Sheffield V. C., and Stone E. M.. 2002. Variations in the myocilin gene in patients with open-angle glaucoma. Arch. Ophthalmol. 120:1189–1197.
   PubMed Web of Science ®Google Scholar
• Borras, T., Rowlette L. L., Tamm E. R., Gottanka J., and Epstein D. L.. 2002. Effects of elevated intraocular pressure on outflow facility and TIGR/MYOC expression in perfused human anterior segments. Investig. Ophthalmol. Vis. Sci. 43:33–40.
   PubMedGoogle Scholar
• Caballero, M., and Borras T.. 2001. Inefficient processing of an olfactomedin-deficient myocilin mutant: potential physiological relevance to glaucoma. Biochem. Biophys. Res. Commun. 282:662–670.
   PubMedGoogle Scholar
• Caballero, M., Rowlette L. L., and Borras T.. 2000. Altered secretion of a TIGR/MYOC mutant lacking the olfactomedin domain. Biochim. Biophys. Acta 1502:447–460.
   PubMedGoogle Scholar
• Chew, S. 1996. Animal models of glaucoma, p. 55–69. In Ritch R., Shields M. B., and Krupin T. (ed.), The glaucomas, basic sciences, 2nd ed., vol. 1. Mosby-Year Book, St. Louis, Mo.
   Google Scholar
• Clark, A. F., Kawase K., English-Wright S., Lane D., Steely H. T., Yamamoto T., Kitazawa Y., Kwon Y. H., Fingert J. H., Swiderski R. E., Mullins R. F., Hageman G. S., Alward W. L., Sheffield V. C., and Stone E. M.. 2001. Expression of the glaucoma gene myocilin (MYOC) in the human optic nerve head. FASEB J. 15:1251–1253.
   PubMed Web of Science ®Google Scholar
• Clark, A. F., Steely H. T., Dickerson J. E., Jr., English-Wright S., Stropki K., McCartney M. D., Jacobson N., Shepard A. R., Clark J. I., Matsushima H., Peskind E. R., Leverenz J. B., Wilkinson C. W., Swiderski R. E., Fingert J. H., Sheffield V. C., and Stone E. M.. 2001. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. Investig. Ophthalmol. Vis. Sci. 42:1769–1780.
   PubMed Web of Science ®Google Scholar
• Clark, A. F., Wilson K., de Kater A. W., Allingham R. R., and McCartney M. D.. 1995. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Investig. Ophthalmol. Vis. Sci. 36:478–489.
   PubMed Web of Science ®Google Scholar
• Colomb, E., Nguyen T. D., Bechetoille A., Dascotte J. C., Valtot F., Brezin A. P., Berkani M., Copin B., Gomez L., Polansky J. R., and Garchon H. J.. 2001. Association of a single nucleotide polymorphism in the TIGR/MYOCILIN gene promoter with the severity of primary open-angle glaucoma. Clin. Genet. 60:220–225.
   PubMedGoogle Scholar
• Copin, B., Brezin A. P., Valtot F., Dascotte J. C., Bechetoille A., and Garchon H. J.. 2002. Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene. Am. J. Hum. Genet. 70:1575–1581.
   PubMed Web of Science ®Google Scholar
• Fautsch, M. P., Bahler C. K., Jewison D. J., and Johnson D. H.. 2000. Recombinant TIGR/MYOC increases outflow resistance in the human anterior segment. Investig. Ophthalmol. Vis. Sci. 41:4163–4168.
   PubMed Web of Science ®Google Scholar
• Fingert, J. H., Clark A. F., Craig J. E., Alward W. L., Snibson G. R., McLaughlin M., Tuttle L., Mackey D. A., Sheffield V. C., and Stone E. M.. 2001. Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension. Investig. Ophthalmol. Vis. Sci. 42:145–152.
   PubMed Web of Science ®Google Scholar
• Fingert, J. H., Heon E., Liebmann J. M., Yamamoto T., Craig J. E., Rait J., Kawase K., Hoh S. T., Buys Y. M., Dickinson J., Hockey R. R., Williams-Lyn D., Trope G., Kitazawa Y., Ritch R., Mackey D. A., Alward W. L., Sheffield V. C., and Stone E. M.. 1999. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum. Mol. Genet. 8:899–905.
   PubMed Web of Science ®Google Scholar
• Hawes, N. L., Smith R. S., Chang B., Davisson M., Heckenlively J. R., and John S. W.. 1999. Mouse fundus photography and angiography: a catalogue of normal and mutant phenotypes. Mol. Vis. 5:22. [Online.] http://www.molvis.org/molvis/v5p22/.
   PubMed Web of Science ®Google Scholar
• Jacobson, N., Andrews M., Shepard A. R., Nishimura D., Searby C., Fingert J. H., Hageman G., Mullins R., Davidson B. L., Kwon Y. H., Alward W. L., Stone E. M., Clark A. F., and Sheffield V. C.. 2001. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum. Mol. Genet. 10:117–125.
   PubMed Web of Science ®Google Scholar
• Joe, M. K., Sohn S., Hur W., Moon Y., Choi Y. R., and Kee C.. 2003. Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabecular meshwork cells. Biochem. Biophys. Res. Commun. 312:592–600.
   PubMed Web of Science ®Google Scholar
• John, S. W., Hagaman J. R., MacTaggart T. E., Peng L., and Smithes O.. 1997. Intraocular pressure in inbred mouse strains. Investig. Ophthalmol. Vis. Sci. 38:249–253.
   PubMedGoogle Scholar
• Johnson, D., Gottanka J., Flugel C., Hoffmann F., Futa R., and Lutjen-Drecoll E.. 1997. Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch. Ophthalmol. 115:375–383.
   PubMedGoogle Scholar
• Karali, A., Russell P., Stefani F. H., and Tamm E. R.. 2000. Localization of myocilin/trabecular meshwork-inducible glucocorticoid response protein in the human eye. Investig. Ophthalmol. Vis. Sci. 41:729–740.
   PubMed Web of Science ®Google Scholar
• Kim, B. S., Savinova O. V., Reedy M. V., Martin J., Lun Y., Gan L., Smith R. S., Tomarev S. I., John S. W., and Johnson R. L.. 2001. Targeted disruption of the myocilin gene (Myoc) suggests that human glaucoma-causing mutations are gain of function. Mol. Cell. Biol. 21:7707–7713.
   PubMed Web of Science ®Google Scholar
• Lam, D. S., Leung Y. F., Chua J. K., Baum L., Fan D. S., Choy K. W., and Pang C. P.. 2000. Truncations in the TIGR gene in individuals with and without primary open-angle glaucoma. Investig. Ophthalmol. Vis. Sci. 41:1386–1391.
   PubMed Web of Science ®Google Scholar
• Lo, W. R., Rowlette L. L., Caballero M., Yang P., Hernandez M. R., and Borras T.. 2003. Tissue differential microarray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma. Investig. Ophthalmol. Vis. Sci. 44:473–485.
   PubMed Web of Science ®Google Scholar
• Lutjen-Drecoll, E., May C. A., Polansky J. R., Johnson D. H., Bloemendal H., and Nguyen T. D.. 1998. Localization of the stress proteins alpha B-crystallin and trabecular meshwork inducible glucocorticoid response protein in normal and glaucomatous trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 39:517–525.
   PubMed Web of Science ®Google Scholar
• Lutjen-Drecoll, E., Shimizu T., Rohrbach M., and Rohen J. W.. 1986. Quantitative analysis of 'plaque material' in the inner- and outer wall of Schlemm's canal in normal- and glaucomatous eyes. Exp. Eye Res. 42:443–455.
   PubMed Web of Science ®Google Scholar
• Nguyen, T. D., Chen P., Huang W. D., Chen H., Johnson D., and Polansky J. R.. 1998. Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J. Biol. Chem. 273:6341–6350.
   PubMedGoogle Scholar
• Pang, C. P., Leung Y. F., Fan B., Baum L., Tong W. C., Lee W. S., Chua J. K., Fan D. S., Liu Y., and Lam D. S.. 2002. TIGR/MYOC gene sequence alterations in individuals with and without primary open-angle glaucoma. Investig. Ophthalmol. Vis. Sci. 43:3231–3235.
   PubMedGoogle Scholar
• Polansky, J. R., Fauss D. J., Chen P., Chen H., Lutjen Drecoll E., Johnson D., Kurtz R. M., Ma Z. D., Bloom E., and Nguyen T. D.. 1997. Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica 211:126–139.
   PubMed Web of Science ®Google Scholar
• Polansky, J. R., Juster R. P., and Spaeth G. L.. 2003. Association of the myocilin mt.1 promoter variant with the worsening of glaucomatous disease over time. Clin. Genet. 64:18–27.
   PubMedGoogle Scholar
• Quigley, H. A. 1996. Number of people with glaucoma worldwide. Br. J. Ophthalmol. 80:389–393.
   PubMed Web of Science ®Google Scholar
• Ritch, R., Shields M. B., and Krupin T.. 1996. The glaucomas, clinical science, 2nd ed., vol. 2. Mosby-Year Book, St. Louis, Mo.
   Google Scholar
• Sarfarazi, M., Child A., Stoilova D., Brice G., Desai T., Trifan O. C., Poinoosawmy D., and Crick R. P.. 1998. Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region. Am. J. Hum. Genet. 62:641–652.
   PubMed Web of Science ®Google Scholar
• Savinova, O. V., Sugiyama F., Martin J. E., Tomarev S. I., Paigen B. J., Smith R. S., and John S. W.. 2001. Intraocular pressure in genetically distinct mice: an update and strain survey. BMC Genet. 2:12. [Online.] http://www.biomedcentral.com/1471-2156/.
   PubMed Web of Science ®Google Scholar
• Sheffield, V. C., Stone E. M., Alward W. L., Drack A. V., Johnson A. T., Streb L. M., and Nichols B. E.. 1993. Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31. Nat. Genet. 4:47–50.
   PubMed Web of Science ®Google Scholar
• Shepard, A. R., Jacobson N., Fingert J. H., Stone E. M., Sheffield V. C., and Clark A. F.. 2001. Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells. Investig. Ophthalmol. Vis. Sci. 42:3173–3181.
   PubMed Web of Science ®Google Scholar
• Shields, M. B. 1992. Textbook of glaucoma, third ed. Williams & Wilkins, Baltimore, Md.
   Google Scholar
• Skuta, G. L., and Morgan R. K.. 1989. Corticosteroid-induced glaucoma, p. 1177–1188. In Ritch R., Shields M. B., and Krupin T. (ed.), The glaucomas, second ed. C. V. Mosby, St. Louis, Mo.
   Google Scholar
• Smith, R. S., Hawes N. L., Miller J., Sundberg J. P., and John S. W. M.. 2002. Photography and necropsy, p. 251–264. In Smith R. S., John S. W. M., Nishina P. M., and Sundberg J. P. (ed.), Systematic evaluation of the mouse eye: anatomy, pathology and biomethods. CRC Press, Inc., Boca Raton, Fla.
   Google Scholar
• Smith, R. S., Zabaleta A., Kume T., Savinova O. V., Kidson S. H., Martin J. E., Nishimura D. Y., Alward W. L., Hogan B. L., and John S. W.. 2000. Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum. Mol. Genet. 9:1021–1032.
   PubMed Web of Science ®Google Scholar
• Smith, R. S., Zabeleta A., John S. W. M., Bechtold L. S., Ikeda S., Relyea M. J., Sundberg J. P., Kao W.-Y., and Liu C.-Y.. 2002. General and specific histopathology, p. 265–297. In Smith R. S., John S. W. M., Nishina P. M., and Sundberg J. P. (ed.), Systematic evaluation of the mouse eye: anatomy, pathology and biomethods. CRC Press, Inc., Boca Raton, Fla.
   Google Scholar
• Sommer, A., Tielsch J. M., Katz J., Quigley H. A., Gottsch J. D., Javitt J., and Singh K.. 1991. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey. Arch. Ophthalmol. 109:1090–1095.
   PubMed Web of Science ®Google Scholar
• Stoilova, D., Child A., Trifan O. C., Crick R. P., Coakes R. L., and Sarfarazi M.. 1996. Localization of a locus (GLC1B) for adult-onset primary open angle glaucoma to the 2cen-q13 region. Genomics 36:142–150.
   PubMed Web of Science ®Google Scholar
• Stone, E. M., Fingert J. H., Alward W. L., Nguyen T. D., Polansky J. R., Sunden S. L., Nishimura D., Clark A. F., Nystuen A., Nichols B. E., Mackey D. A., Ritch R., Kalenak J. W., Craven E. R., and Sheffield V. C.. 1997. Identification of a gene that causes primary open angle glaucoma. Science 275:668–670.
   PubMed Web of Science ®Google Scholar
• Swiderski, R. E., Ross J. L., Fingert J. H., Clark A. F., Alward W. L., Stone E. M., and Sheffield V. C.. 2000. Localization of MYOC transcripts in human eye and optic nerve by in situ hybridization. Investig. Ophthalmol. Vis. Sci. 41:3420–3428.
   PubMed Web of Science ®Google Scholar
• Tamm, E. R., Russell P., Epstein D. L., Johnson D. H., and Piatigorsky J.. 1999. Modulation of myocilin/TIGR expression in human trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 40:2577–2582.
   PubMedGoogle Scholar
• Thylefors, B., and Negrel A. D.. 1994. The global impact of glaucoma. Bull. W. H. O. 72:323–326.
   PubMed Web of Science ®Google Scholar
• Tielsch, J. M., Katz J., Singh K., Quigley H. A., Gottsch J. D., Javitt J., and Sommer A.. 1991. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am. J. Epidemiol. 134:1102–1110.
   PubMed Web of Science ®Google Scholar
• Tomarev, S. I., Tamm E. R., and Chang B.. 1998. Characterization of the mouse Myoc/Tigr gene. Biochem. Biophys. Res. Commun. 245:887–893.
   PubMedGoogle Scholar
• Trifan, O. C., Traboulsi E. I., Stoilova D., Alozie I., Nguyen R., Raja S., and Sarfarazi M.. 1998. A third locus (GLC1D) for adult-onset primary open-angle glaucoma maps to the 8q23 region. Am. J. Ophthalmol. 126:17–28.
   PubMed Web of Science ®Google Scholar
• Wiggs, J. L., and Vollrath D.. 2001. Molecular and clinical evaluation of a patient hemizygous for TIGR/MYOC. Arch. Ophthalmol. 119:1674–1678.
   PubMedGoogle Scholar
• Wirtz, M. K., Samples J. R., Kramer P. L., Rust K., Topinka J. R., Yount J., Koler R. D., and Acott T. S.. 1997. Mapping a gene for adult-onset primary open-angle glaucoma to chromosome 3q. Am. J. Hum. Genet. 60:296–304.
   PubMed Web of Science ®Google Scholar
• Wirtz, M. K., Samples J. R., Rust K., Lie J., Nordling L., Schilling K., Acott T. S., and Kramer P. L.. 1999. GLC1F, a new primary open-angle glaucoma locus, maps to 7q35-q36. Arch. Ophthalmol. 117:237–241.
   PubMed Web of Science ®Google Scholar
• Wordinger, R. J., and Clark A. F.. 1999. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog. Retin. Eye Res. 18:629–667.
   PubMed Web of Science ®Google Scholar